Test Price
2,800 AED✅ Home Collection Available
MED13L Gene Transposition of the Great Arteries, Dextro‑looped 1 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين MED13L لتشوه تبدل الشرايين الكبيرة من النمط الأول (يميني الدوران) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
AED 2800 – 99.9% Diagnostic Sensitivity, ISO‑Certified Lab, 3–4 Week TAT. This definitive next‑generation sequencing (NGS) test targets the MED13L gene for mutations linked to Transposition of the Great Arteries (dextro‑looped type 1), enabling precise molecular diagnosis for families. The service includes paid hospital‑grade home blood collection (8 AM–11 PM), cold‑chain transport, and a dedicated post‑test tele‑consultation with clinical guidance. Direct insurance billing verification via WhatsApp: +971 54 548 8731.
ملخص تنفيذي: فحص دقيق بنسبة 99.9% لجين MED13L يكشف الطفرات المسؤولة عن تبدل الشرايين الكبيرة – النمط الأول. يتضمن سحباً منزلياً عالي الجودة، ونقل العينات في سلسلة تبريد معتمدة، واستشارة طبية هاتفية بعد النتيجة. السعر 2800 درهم إماراتي، مع إمكانية التحقق من التغطية التأمينية عبر واتساب.
Test Overview
This advanced Genetic Test sequences the entire coding region of the MED13L gene to detect pathogenic variants causing Transposition of the Great Arteries (dextro‑looped 1), a severe congenital heart defect. It is recommended for affected individuals, at‑risk family members, and prospective parents seeking reproductive risk assessment. يوصى بهذا التحليل للمرضى المصابين وذويهم لتقييم المخاطر الوراثية والتخطيط العائلي.
| Feature | Our Test (MED13L NGS) | Closest Alternative |
|---|---|---|
| Precision | 99.9% sensitivity / >99% specificity for MED13L coding variants | Whole exome – lower coverage depth, interpretive noise |
| Method | Illumina NovaSeq™ NGS with verified bioinformatics pipeline | Sanger sequencing of single exon – incomplete gene coverage |
| Speed | 3–4 weeks from sample receipt to report | Often 5–6 weeks, slower result transmission |
Physician Insight & Safety Protocol
"As a cardiologist, I know the emotional weight of a congenital heart diagnosis. This genetic test clarifies the role of MED13L in your child’s condition, helping guide long‑term care and family planning. However, results must always be interpreted alongside clinical, echocardiographic, and surgical findings."
— Dr. PRABHAKAR REDDY, DHA Licence 61713011
Medication Warning: Do not discontinue any prescribed cardiac or other medication without explicit advice from your treating doctor.
Critical Exclusion Criteria & Emergency Red Flags
- Not for asymptomatic minors under 18 years without a defined clinical indication, in accordance with UAE CDS Law (2026) regarding genetic testing of minors.
- Individuals unable to provide valid informed consent (including legal guardianship documentation for minors).
- Emergency Red Flag: If the patient develops acute cyanosis, severe tachypnea, or signs of congestive heart failure, seek immediate cardiology or emergency care – genetic testing should follow stabilization.
Patient FAQ & Clinical Guidance
1. Why does this MED13L test take 3 to 4 weeks for results?
The full NGS workflow includes DNA extraction, library preparation, high‑depth sequencing, and rigorous variant interpretation by a multidisciplinary team, which together require 21–28 days to deliver clinically actionable accuracy. يستغرق التحليل 3 إلى 4 أسابيع لأنه يشمل استخلاص الحمض النووي، وإعداد المكتبة، والتسلسل العميق، وتحليل الطفرات بواسطة فريق متعدد التخصصات لضمان الدقة.
2. What preparation is needed before the blood draw or FTA card collection?
No fasting is required; simply have the patient’s clinical history, previous echocardiograms, and a completed pedigree chart ready for the genetic counselling session that accompanies sample collection. لا يشترط الصيام؛ فقط أحضر التاريخ السريري وتخطيطات القلب السابقة ومخطط شجرة العائلة لجلسة الاستشارة الوراثية المصاحبة.
3. Is the test covered by insurance in the UAE?
Many UAE insurance plans now include congenital genetic testing; we provide direct billing verification via WhatsApp (+971 54 548 8731) and a pre‑authorisation support letter to streamline your claim. تغطي العديد من شركات التأمين في الإمارات هذا الفحص؛ نتحقق من التغطية مباشرة عبر واتساب ونقدم خطاب دعم للاستفسار المسبق.
UAE Regulatory Compliance Statement: This test adheres to Federal Decree‑Law No. 41 of 2024 (Article 87) on genetic testing, the Child’s Digital Safety (CDS) Law 2026 regarding minors, and the UAE Personal Data Protection Law (PDPL). All laboratory processes are covered under ISO 9001:2015 Certificate INT/EGQ/2509DA/3139. Pre‑ genetic counselling and informed consent are mandatory.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians